🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This study will examine the safety, pharmacokinetics, and efficacy of escal...
Status
Terminated
Location
City of Hope National Medical Center ( Site 0004)
Start Date
2019-03-18
Trial ID
NCT03833427
Treatments Being Tested
Background: \- The experimental cancer treatment drug AZD6244 has been sho...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-01-07
Trial ID
NCT01287130
A study to assess the pharmacokinetics, safety and tolerability of Selumeti...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02063230
Treatments Being Tested
The primary purpose of the study is to assess the safety, tolerability and ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2007-03-08
Trial ID
NCT00463814
Treatments Being Tested
Background: \- The current standard of care for advanced lung cancer and c...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2011-02-08
Trial ID
NCT01306045
This phase II trial studies the side effects and how well selumetinib sulfa...
Status
Completed
Location
USC / Norris Comprehensive Cancer Center
Start Date
2007-12-17
Trial ID
NCT00551070
Treatments Being Tested
This randomized phase II trial is studying how well giving selumetinib toge...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2010-10
Trial ID
NCT01206140
Treatments Being Tested
The primary purpose of this study is to compare the efficacy of AZD6244 (AR...
Status
Completed
Location
Research Site
Start Date
2006-07
Trial ID
NCT00338130
Treatments Being Tested
Study to assess the effect of Selumetinib \[AZD6244; ARRY-142886\] \[Hyd-Su...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02056392
Treatments Being Tested